Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

3.270 USD -0.120 (-3.54%)
Streaming Delayed Price Updated: 11:29 AM EDT, Oct 26, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Genprex Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Genprex (GNPX) Featured in Publication on Advances in Potential Breast Cancer Treatments
From GlobeNewswire News Releases
Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers
From InvestorBrandNetwork
Gene Therapies with Potential to Conquer Tough-to-Tackle Breast Cancers
NetworkNewsWire Editorial Coverage 
From PR Newswire
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) CEO to Present Via Webcast at September 19 Singular Research Midwestern Values Conference
From InvestorBrandNetwork
Genprex to Present Via Webcast at the Singular Research Midwestern Values Conference on September 19, 2019
Genprex's Chairman and CEO, Rodney Varner, will lead the company's webcast presentation on September 19, 2019. 
From Business Wire News Releases
NetworkNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) TUSC2 Found to Prevent Tumor Growth in Triple-Negative Breast Cancer by Independent Researchers
From InvestorBrandNetwork
Independent Researchers Find Genprex’s TUSC2 Prevents Tumor Growth in Triple-Negative Breast Cancer
Independent researchers find the active agent in Genprex's lead drug candidate may be effective for the treatment of triple-negative breast cancer. 
From Business Wire News Releases
CORRECTING and REPLACING Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Genprex's Chairman and CEO, Rodney Varner, will present at the H.C. Wainwright 21st Annual Global Investment Conference on September 9 in NYC. 
From Business Wire News Releases
NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Developing Revolutionary Gene Therapies to Fight Cancer
From InvestorBrandNetwork
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Lung Cancer and Gene Therapy Treatments
From GlobeNewswire News Releases
NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Issues Corporate Update; Set to Present at H.C. Wainwright 21st Annual Global Investment Conference
From InvestorBrandNetwork
Genprex (GNPX) Featured in NetworkNewsWire Publication Summarizing Gene Therapy Treatment for Lung Cancer
From GlobeNewswire News Releases
Gene Therapy Treatments Offer Hope for Cancer Patients
From InvestorBrandNetwork
Gene Therapy Treatments Offer Hope for Cancer Patients
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex Provides Forward Looking Guidance and Updates on Corporate Activities, Publishes New Corporate Deck
Genprex Releases New Company Milestones in Updated Corporate Presentation 
From Business Wire News Releases
Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector
From GlobeNewswire News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
From GlobeNewswire News Releases
Record Revenues, Milestone Achievements Indicate Strength, Potential of Biotech Sector
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex to Present at the RHK Capital 4th Annual Disruptive Growth Conference
Genprex will present at upcoming conference in New York City on September 4, 2019. 
From Business Wire News Releases
Genprex Demonstrates Growth and Expansion Through Recent Achievements
Genprex announces recent achievements since its IPO 
From Business Wire News Releases
Genprex™ Manufacturing Partner Aldevron Completes Significant Step in Manufacturing for Oncoprex™ Clinical Development Program
Genprex Announces the Completion of Plasmid DNA Manufacturing by Partner, Aldevron 
From Business Wire News Releases
Genprex Begins Next Phase of Drug Branding Program
Genprex Submits Non-proprietary Drug Name Selections to USAN Council. 
From Business Wire News Releases
The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... 
Tags NVAX UBX VCYT
From Benzinga
Genprex Provides Update on Development of its Oncoprex Immunogene Therapy in Combination with Immunotherapy for Non-Small Cell Lung Cancer
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company, today provided an update on development of its lead drug candidate, Oncoprex™ immunogene therapy, in combination with immunotherapy... 
From Business Wire News Releases
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Gene Therapy as Potential Cancer Treatment
via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “Biotechs That Successfully Combat Cancer Could See Blockbuster Returns.” 
From GlobeNewswire News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Hunt for Gene Therapy Breakthroughs
via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and... 
From GlobeNewswire News Releases
Biotechs That Successfully Combat Cancer Could See Blockbuster Returns
NetworkNewsWire Editorial Coverage 
From PR Newswire
Genprex to Present at Sachs 5th Annual Immuno-Oncology BD&L and Investment Forum
Genprex to Present at Sachs Conference in Chicago on May 31, 2019 
From Business Wire News Releases
Genprex (GNPX) Featured in NetworkNewsAudio Publication Discussing Promising New Gene Therapies
via NetworkNewsAudio – Genprex Inc. (NASDAQ:GNPX) announces the availability of a NetworkNewsAudio publication titled, “New Gene Therapies Hold Out Promise for Patients.” 
From GlobeNewswire News Releases
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Gene Therapies for Cancer Treatment
via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and... 
From GlobeNewswire News Releases
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.